To us, sustainability is about creating value for Duopharma Biotech and our stakeholders while ensuring global environmental sustainability, which is critical to the well-being of everyone.
Since embarking on our sustainability journey in 2016, we have taken steps to reduce our emissions and environmental impact and improve the sustainability of our manufacturing process and materials. We have maintained and improved our ability to provide consumers and patients with access to the medicines and therapies they need for better health. We have also strengthened our team diversity to promote more inclusive perspectives, as well as refined our management system and corporate culture.
Guided by these priorities, Duopharma Biotech is committed to:
These commitments support global efforts to address climate change, contribute towards Malaysia’s net-zero ambitions and advance the United Nations Sustainable Development Goals (UN SDGs), while fostering an inclusive, responsible and resilient workplace.
As sustainability expectations continue to evolve, Duopharma Biotech is strengthening the integration of ESG into our strategy, governance, risk management and decision-making. In line with Malaysia’s National Sustainability Reporting Framework (NSRF), we are progressively aligning with the IFRS S1 and IFRS S2 Sustainability Disclosure Standards to enhance our management of sustainability and climate-related risks and opportunities, supporting informed decision-making and long-term business resilience.